Home > Boards > US Listed > Biotechs > Cassava Sciences Inc (SAVA)

DO you think there is possibility that relatives

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ranchhand71 Member Profile
 
Followed By 5
Posts 726
Boards Moderated 0
Alias Born 12/22/17
160x600 placeholder
Cassava Sciences to Present at the Raymond James 2021 Human Health Innovation Conference GlobeNewswire Inc. - 6/17/2021 4:01:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/14/2021 4:23:38 PM
Alzheimer's-focused Cassava Sciences adds Richard Barry to its board of directors Seeking Alpha - 6/14/2021 8:49:02 AM
Cassava Sciences Announces the Appointment of Richard J. Barry to its Board of Directors GlobeNewswire Inc. - 6/14/2021 8:30:00 AM
Cassava’s Alzheimer’s Drug Is Potentially Better Than Biogen’s, Says Analyst TipRanks - 6/10/2021 8:16:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2021 4:02:23 PM
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease GlobeNewswire Inc. - 5/24/2021 8:30:00 AM
Cassava Sciences granted $2.7M in new research grant from NIH Seeking Alpha - 5/12/2021 7:49:51 AM
Cassava Sciences Announces New $2.7 Million Research Grant Award from National Institutes of Health GlobeNewswire Inc. - 5/12/2021 7:30:00 AM
Cassava Sciences Announces Initiation of Cognition Maintenance Study in Alzheimer’s disease GlobeNewswire Inc. - 5/10/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 4:10:33 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/29/2021 4:53:15 PM
Cassava: Breaking Down B. Riley’s New Bullish Call TipRanks - 4/27/2021 1:08:24 PM
Cassava Sciences Invited to Participate in B. Riley Securities’ Neuroscience Conference GlobeNewswire Inc. - 4/27/2021 8:30:00 AM
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum GlobeNewswire Inc. - 4/26/2021 8:30:00 AM
Cassava Sciences Stock at $110 a Share? This Analyst Thinks It’s Possible TipRanks - 4/22/2021 10:26:52 PM
Cassava to release further analysis of Alzheimer's drug simufilam in July; shares rise 7% Seeking Alpha - 4/21/2021 1:19:49 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/21/2021 8:45:40 AM
Cassava Sciences EPS misses by $0.01; outlook Seeking Alpha - 4/21/2021 8:43:10 AM
Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release GlobeNewswire Inc. - 4/21/2021 8:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 3/31/2021 4:26:07 PM
Annual Report (10-k) Edgar (US Regulatory) - 3/23/2021 5:06:33 PM
Cassava Sciences EPS misses by $0.04 Seeking Alpha - 3/23/2021 9:28:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/23/2021 8:55:58 AM
Cassava Sciences Announces Full-year 2020 Financial Results and Business Highlights GlobeNewswire Inc. - 3/23/2021 8:30:00 AM
ranchhand71   Monday, 04/19/21 09:17:31 AM
Re: Optionsrbest4u post# 1805
Post # of 1867 
DO you think there is possibility that relatives of patients being treated in the trials will get a useful sense of effectiveness?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences